Literature DB >> 4640950

Effect of experimental chronic renal insufficiency on bone mineral and collagen maturation.

J E Russell, L V Avioli.   

Abstract

The effect of chronic renal disease on bone matrix and mineral maturation was evaluated in rats with experimental renal insufficiency of 2-11 wk duration utilizing bromoform-toluene gradient fractionation of bone powder, pulse labeling experiments with (45)Ca and proline-(3)H differential extraction, and X-ray diffraction techniques.Maturation defects in both collagen and mineral ((45)Ca) metabolism were documented as early as 2 wk after the induction of uremia, when total bone calcium, inorganic phosphate, and hydroxyproline content were unchanged. The maturational defect progressed with advancing uremia despite insignificant changes in plasma pH and calcium, and normal bone carbonate levels. Although circulating levels of 25-hydroxycholecalciferol were significantly lower than normal in the uremic animals, pretreatment with either this vitamin D metabolite or vitamin D(3) itself failed to alter the observed changes in skeletal maturation.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4640950      PMCID: PMC332989          DOI: 10.1172/JCI107134

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

Review 1.  Bone disease in uremia.

Authors:  S W Stanbury
Journal:  Am J Med       Date:  1968-05       Impact factor: 4.965

Review 2.  The composition of human bone in uremia. Observations on the reservoir functions of bone and demonstration of a labile fraction of bone carbonate.

Authors:  E D Pellegrino; R M Biltz
Journal:  Medicine (Baltimore)       Date:  1965-09       Impact factor: 1.889

Review 3.  The metabolism of bone tissue in vitro.

Authors:  W A Peck; T R Dirksen
Journal:  Clin Orthop Relat Res       Date:  1966 Sep-Oct       Impact factor: 4.176

4.  Calcium metabolism in chronic renal failure.

Authors:  M Kaye; M Silverman
Journal:  J Lab Clin Med       Date:  1965-10

5.  The biosynthesis of elastin cross-links. The effect of copper deficiency and a lathyrogen.

Authors:  E J Miller; G R Martin; C E Mecca; K A Piez
Journal:  J Biol Chem       Date:  1965-09       Impact factor: 5.157

6.  Parathyroid-induced changes in collagen and calcium metabolism in vivo.

Authors:  O Laitinen
Journal:  Endocrinology       Date:  1967-05       Impact factor: 4.736

7.  Parathyroid function in chronic renal failure. A statistical survey of the plasma biochemistry in azotaemic renal osteodystrophy.

Authors:  S W Stanbury; G A Lumb
Journal:  Q J Med       Date:  1966-01

8.  Amorphous/crystalline interrelationships in bone mineral.

Authors:  J D Termine; A S Posner
Journal:  Calcif Tissue Res       Date:  1967

9.  Inhibition of collagen intermolecular cross-linking by thiosemicarbazide.

Authors:  M L Tanzer; D Monroe; J Gross
Journal:  Biochemistry       Date:  1966-06       Impact factor: 3.162

10.  The effects of chronic acid loads in normal man: further evidence for the participation of bone mineral in the defense against chronic metabolic acidosis.

Authors:  J Lemann; J R Litzow; E J Lennon
Journal:  J Clin Invest       Date:  1966-10       Impact factor: 14.808

View more
  25 in total

1.  Bone maturation in the vitamin D, phosphate deficient rat and the response to acid loading.

Authors:  J E Russell; L V Avioli
Journal:  Calcif Tissue Int       Date:  1979-07-03       Impact factor: 4.333

2.  Dissociation of renal cyclic AMP and phosphate responses to parathyroid hormone in uremia.

Authors:  J E Russell; M Kleerekoper; E Slatopolsky; J Lewis; S W Lee; L V Avioli
Journal:  Calcif Tissue Int       Date:  1979-11-26       Impact factor: 4.333

3.  Effect of sodium fluoride on bone density in chickens.

Authors:  M W Lundy; J E Russell; J Avery; J E Wergedal; D J Baylink
Journal:  Calcif Tissue Int       Date:  1992-05       Impact factor: 4.333

4.  Phosphate control and 25-hydroxycholecalciferol administration in preventing experimental renal osteodystrophy in the dog.

Authors:  W E Rutherford; P Bordier; P Marie; K Hruska; H Harter; A Greenwalt; J Blondin; J Haddad; N Bricker; E Slatopolsky
Journal:  J Clin Invest       Date:  1977-08       Impact factor: 14.808

5.  25-OH-Vitamin D in experimental and clinical uremia.

Authors:  H Schmidt-Gayk; E Ritz; O Mehls; J Goossen; P Förster
Journal:  Calcif Tissue Res       Date:  1977-05

6.  The regulation of skeletal muscle alanine and glutamine formation and release in experimental chronic uremia in the rat: subsensitivity of adenylate cyclase and amino acid release to epinephrine and serotonin.

Authors:  A J Garber
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

7.  Glucagon-stimulable adenylyl cyclase in rat liver. Effects of chronic uremia and intermittent glucagon administration.

Authors:  R R Dighe; F J Rojas; L Birnbaumer; A J Garber
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

8.  Bone magnesium pools in uremia.

Authors:  A C Alfrey; N L Miller
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

9.  Bone crystal maturation in renal osteodystrophy in humans.

Authors:  J M Burnell; E Teubner; J E Wergedal; D J Sherrard
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

10.  Skeletal muscle protein and amino acid metabolism in experimental chronic uremia in the rat: accelerated alanine and glutamine formation and release.

Authors:  A J Garber
Journal:  J Clin Invest       Date:  1978-09       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.